Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Double Blind, Randomized, Multicenter Study to Evaluate the Utility, Safety, and Efficacy of Using PEER Interactive to Inform the Prescription of Medications to Patients With a Primary Diagnosis of a Depressive Disorder Versus Treatment as Usual.

NCT01794559 is registered in ClinicalTrials.gov with MYnd Analytics as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01794559 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Double Blind, Randomized, Multicenter Study to Evaluate the Utility, Safety, and Efficacy of Using PEER Interactive to Inform the Prescription of Medications to Patients With a Primary Diagnosis of a Depressive Disorder Versus Treatment as Usual.
Lead sponsor
MYnd Analytics
Phase
Not applicable
Overall status
Suspended
Start date
March 1, 2013
Completion date
June 30, 2022
Enrollment
1,922 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.